LogicBio Therapeutics Inc
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price 2.07
Ask Price 1.75
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
LogicBio Therapeutics Inc LOGC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.07 19:00:00
Open Price Low Price High Price Close Price Prev Close
2.07 2.07
Trades Volume Avg Volume 52 Week Range
0 0 - 0.2573 - 2.07
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.07 USD


Draw Mode:

LogicBio Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 68.23M 32.96M 23.42M $ 5.41M $ - -1.24 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 1.80%

more financials information »

LogicBio Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LOGC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months2.,2690.010.49%
6 Months0.412.070.25731.63490,3281.66404.88%
1 Year1.532.070.25730.8908171705,0950.5435.29%
3 Years9.9311.59660.25732.42284,171-7.86-79.15%
5 Years10.7120.0710.25732.92209,312-8.64-80.67%

LogicBio Therapeutics Description

LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.